2020 Q3 Form 10-Q Financial Statement

#000087401520000142 Filed on November 04, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3
Revenue $160.1M $167.9M
YoY Change -4.64% 15.47%
Cost Of Revenue $3.100M $1.000M
YoY Change 210.0%
Gross Profit $157.0M $166.9M
YoY Change -5.93%
Gross Profit Margin 98.06% 99.41%
Selling, General & Admin $68.40M $60.00M
YoY Change 14.0% -12.66%
% of Gross Profit 43.57% 35.95%
Research & Development $125.1M $104.4M
YoY Change 19.83% 9.55%
% of Gross Profit 79.68% 62.55%
Depreciation & Amortization $3.800M $3.200M
YoY Change 18.75% -3.03%
% of Gross Profit 2.42% 1.92%
Operating Expenses $193.5M $164.4M
YoY Change 17.7% 0.24%
Operating Profit -$36.50M $2.523M
YoY Change -1546.69% -113.58%
Interest Expense $2.428M $1.100M
YoY Change 120.73% -184.62%
% of Operating Profit 43.6%
Other Income/Expense, Net $100.0K -$100.0K
YoY Change -200.0%
Pretax Income -$31.55M $3.500M
YoY Change -1001.43% -117.59%
Income Tax $5.064M -$14.90M
% Of Pretax Income -425.71%
Net Earnings -$24.47M $26.16M
YoY Change -193.52% -673.88%
Net Earnings / Revenue -15.28% 15.58%
Basic Earnings Per Share -$0.18 $0.19
Diluted Earnings Per Share -$0.18 $0.18
COMMON SHARES
Basic Shares Outstanding 139.7M 140.6M
Diluted Shares Outstanding 139.7M 143.4M

Balance Sheet

Concept 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.329B $2.221B
YoY Change 4.88% 13.36%
Cash & Equivalents $633.1M $247.9M
Short-Term Investments $1.696B $1.973B
Other Short-Term Assets $146.6M $118.8M
YoY Change 23.4% 22.35%
Inventory $22.20M $19.40M
Prepaid Expenses
Receivables $39.00M $49.10M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.537B $2.408B
YoY Change 5.35% 15.82%
LONG-TERM ASSETS
Property, Plant & Equipment $181.5M $161.7M
YoY Change 12.24% 22.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $348.9M $298.2M
YoY Change 17.0% 2248.03%
Total Long-Term Assets $558.7M $486.9M
YoY Change 14.75% 188.62%
TOTAL ASSETS
Total Short-Term Assets $2.537B $2.408B
Total Long-Term Assets $558.7M $486.9M
Total Assets $3.096B $2.895B
YoY Change 6.93% 28.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.20M $13.10M
YoY Change 23.66% -3.68%
Accrued Expenses $109.1M $79.10M
YoY Change 37.93% 5.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $5.800M
YoY Change
Total Short-Term Liabilities $244.6M $231.8M
YoY Change 5.52% -10.91%
LONG-TERM LIABILITIES
Long-Term Debt $814.8M $656.7M
YoY Change 24.07% 5.22%
Other Long-Term Liabilities $429.9M $508.6M
YoY Change -15.47% -2.83%
Total Long-Term Liabilities $1.245B $1.165B
YoY Change 6.81% 1.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $244.6M $231.8M
Total Long-Term Liabilities $1.245B $1.165B
Total Liabilities $1.713B $1.559B
YoY Change 9.87% 1.39%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.383B $1.336B
YoY Change
Total Liabilities & Shareholders Equity $3.096B $2.895B
YoY Change 6.93% 28.79%

Cashflow Statement

Concept 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$24.47M $26.16M
YoY Change -193.52% -673.88%
Depreciation, Depletion And Amortization $3.800M $3.200M
YoY Change 18.75% -3.03%
Cash From Operating Activities -$10.40M -$12.80M
YoY Change -18.75% -50.77%
INVESTING ACTIVITIES
Capital Expenditures -$11.80M -$15.90M
YoY Change -25.79% 396.88%
Acquisitions
YoY Change
Other Investing Activities $113.7M $17.30M
YoY Change 557.23% -105.68%
Cash From Investing Activities $101.9M $1.400M
YoY Change 7178.57% -100.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 11.00M -13.20M
YoY Change -183.33% -262.96%
NET CHANGE
Cash From Operating Activities -10.40M -12.80M
Cash From Investing Activities 101.9M 1.400M
Cash From Financing Activities 11.00M -13.20M
Net Change In Cash 102.5M -24.60M
YoY Change -516.67% -92.44%
FREE CASH FLOW
Cash From Operating Activities -$10.40M -$12.80M
Capital Expenditures -$11.80M -$15.90M
Free Cash Flow $1.400M $3.100M
YoY Change -54.84% -113.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000874015
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-19125
dei Entity Registrant Name
EntityRegistrantName
Ionis Pharmaceuticals, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0336973
dei Entity Address Address Line1
EntityAddressAddressLine1
2855 Gazelle Court
dei Entity Address City Or Town
EntityAddressCityOrTown
Carlsbad
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92010
dei City Area Code
CityAreaCode
760
dei Local Phone Number
LocalPhoneNumber
931-9200
dei Security12b Title
Security12bTitle
Common Stock, $.001 Par Value
dei Trading Symbol
TradingSymbol
IONS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
139823135
us-gaap Income Taxes Paid
IncomeTaxesPaid
9037000
ions Number Of Investments In Privately Held Companies That Were Revalued
NumberOfInvestmentsInPrivatelyHeldCompaniesThatWereRevalued
2
us-gaap Income Taxes Paid
IncomeTaxesPaid
23532000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
358000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
14178000
ions Acquisition Transaction Costs Incurred But Not Yet Paid
AcquisitionTransactionCostsIncurredButNotYetPaid
8103000
ions Acquisition Transaction Costs Incurred But Not Yet Paid
AcquisitionTransactionCostsIncurredButNotYetPaid
0
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
1071000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
12500000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
26158000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140551000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2019Q3 ions Incremental Common Shares Attributable To Employee Stock Purchase Plan
IncrementalCommonSharesAttributableToEmployeeStockPurchasePlan
20000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
26158000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143408000
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2020Q4 ions Cash Purchase Price Of Equity Awards
CashPurchasePriceOfEquityAwards
18.15
CY2020Q4 ions Cash Purchase Price Of Equity Awards
CashPurchasePriceOfEquityAwards
18.15
CY2020Q4 ions Cash Purchase Price Of Equity Awards
CashPurchasePriceOfEquityAwards
18.15

Files In Submission

Name View Source Status
0000874015-20-000142-index-headers.html Edgar Link pending
0000874015-20-000142-index.html Edgar Link pending
0000874015-20-000142.txt Edgar Link pending
0000874015-20-000142-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
form10q_htm.xml Edgar Link completed
ions-20200930.xsd Edgar Link pending
ions-20200930_cal.xml Edgar Link unprocessable
ions-20200930_def.xml Edgar Link unprocessable
ions-20200930_lab.xml Edgar Link unprocessable
ions-20200930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending